VALEOVOX INTRODUCES NEW PROPRIETARY PRODUCT E-XELERATE RX™ ― A BRAND MANAGEMENT TECHNOLOGY THAT SUPPORTS HEALTH INDUSTRY COMPANIES

E-Xcelerate™ Enables Companies To Stay Ahead Of The Curve Despite Market Uncertainty

Boston – As an answer to challenges facing today’s health care industry ― constrained resources, limited budgets and need to focus on non-traditional markets,  ValeoVox,Inc. president and co-founder Amelia Spiliotes, recently unveiled a new brand management technology, e-Xcelerate Rx™, that promises to provide companies with “definitive market intelligence and insights into their business and strategic direction.”

ValeoVox, a business process, product consulting, and software development firm, provides web-based, market-focused solutions to health industry companies and healthcare organizations.  The company’s new technology,  e-Xcelerate Rx™, allows companies to strengthen existing brands and prepare for new product launches through a rapid and intensive market evaluation which explores the drivers of market shifts, what competitors are doing differently, and what companies should do to increase visibility and boost revenues.  

“The market place is much more competitive than in the past.  The research and development pipelines are not as robust today.  This means that companies must shore up their existing brands and current markets and look to expand into new indications and geographical markets,” said Ms. Spiliotes.  “Our new product, can help redefine existing product and marketing strategy and define the market potential of new opportunities for business growth and market competitiveness.”

According to Ms. Spiliotes, e-Xcelerate Rx™ looks at issues to critical questions about strategies and tactics of companies that want to move ahead.  “Specific, customized analytical tools are used to examine markets and answer questions.  The outcome provides a reliable case that the market is there, a product can deliver, there is a clear execution path and the risk is manageable.” 

Ms. Spiliotes says the e-Xcelerate Rx™ method of uncovering and managing  information that companies need diverts from the more traditional approach, an approach that falls short in the requirements to address future challenges.  e-Xcelerate Rx™ combines proven market research methods with effective knowledge management tools to enable companies to stay ahead of the curve despite marketplace uncertainty.

“Companies need to look at data in a different way.  They must be able to dynamically assess, integrate and distribute information via real-time global exchange throughout the organization.  With ‘e-Xcelerate Rx™’ companies can take a close look at how they handle information, how they can address potential problems ahead of time and what efficiencies are needed for companies to get what they need in a reasonable time-frame. Our technology allows companies to maintain a competitive edge,” she said.

For additional information: Celia Doremus, Valeovox, 781-648-2953.

About Valeovox
ValeoVox, Inc. is a business process, product consulting, and software development firm that provides web-based, market-focused solutions to health industry corporations and corporate healthcare organizations. The company recently launched its eWP2.0 product, a web-enabled care coordination program which, when applied to specific diseases such as diabetes, cardiovascular, and depression, aids caregivers to communicate thoroughly and effectively and therefore better manage patient care.